SlideShare uma empresa Scribd logo
1 de 30
GLP
GLP: GOOD LABORATORY PRACTICE ,[object Object],[object Object],[object Object]
HISTORY ,[object Object],[object Object],[object Object],[object Object],[object Object]
WHY WAS GLP CREATED? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
FAMOUS EXAMPLE ,[object Object],[object Object],[object Object],[object Object],[object Object]
OBJECTIVES OF GLP ,[object Object],[object Object],[object Object]
MISSION OF GLP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Standard Operating Procedures (SOP) ,[object Object],[object Object],[object Object],[object Object]
SOP ,[object Object],[object Object],[object Object],[object Object],[object Object]
Statistical Procedures for Data Evaluation ,[object Object],[object Object],[object Object]
Instrumentation Validation ,[object Object],[object Object],[object Object],[object Object]
Instrument Validation (cont) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reagent/ Materials Certification ,[object Object],[object Object]
Reagents and Solutions cont ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Analyst Certification ,[object Object],[object Object],[object Object],[object Object]
Laboratory Certification ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Specimen/Sample Tracking ,[object Object],[object Object],[object Object]
Documentation and Maintenance of Records ,[object Object],[object Object],[object Object]
Important questions to be answered for any analytical instrument ,[object Object],[object Object],[object Object],[object Object],[object Object]
What happens if a workplace does not comply with federal Good Laboratory Practice standards?
Disqualification of a Facility  ,[object Object],[object Object]
Possible Violations ,[object Object],[object Object],[object Object]
Grounds for Disqualification ,[object Object],[object Object],[object Object]
Consequences of Noncompliance ,[object Object],[object Object],[object Object],[object Object],[object Object]
Upon Disqualification… ,[object Object],[object Object],[object Object],[object Object]
Upon Disqualification… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Upon Disqualification… ,[object Object],[object Object],[object Object]
Reinstatement of a Disqualified Facility ,[object Object],[object Object]
Reinstatement of a Disqualified Facility ,[object Object],[object Object]
References ,[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

Good Laboratory Practice Documentation
Good Laboratory Practice DocumentationGood Laboratory Practice Documentation
Good Laboratory Practice Documentation
Sunando Basu
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
Syeda Abeer
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004
Patel Parth
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
Gaurav Kr
 

Mais procurados (20)

GLP - Good Laboratory Practices
GLP - Good Laboratory PracticesGLP - Good Laboratory Practices
GLP - Good Laboratory Practices
 
Nabl certification
Nabl certificationNabl certification
Nabl certification
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticals
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practices
 
Good Laboratory Practice Documentation
Good Laboratory Practice DocumentationGood Laboratory Practice Documentation
Good Laboratory Practice Documentation
 
Out of specification (oos)1
Out of specification (oos)1Out of specification (oos)1
Out of specification (oos)1
 
GOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDYGOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDY
 
CDSCO (regulatory affairs)
CDSCO (regulatory affairs)CDSCO (regulatory affairs)
CDSCO (regulatory affairs)
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug Application
 
clinical trials types and design
clinical trials types and designclinical trials types and design
clinical trials types and design
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
 
PPT ON GOOD LABORATORY PRACTICES (GLP)
PPT ON GOOD LABORATORY PRACTICES (GLP)PPT ON GOOD LABORATORY PRACTICES (GLP)
PPT ON GOOD LABORATORY PRACTICES (GLP)
 
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATIONCDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
 
Concept of glp
Concept of glpConcept of glp
Concept of glp
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
GLP (Good Laboratory Practices)
GLP (Good Laboratory Practices)GLP (Good Laboratory Practices)
GLP (Good Laboratory Practices)
 

Semelhante a Glp

Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
Nasir Nazeer
 
Good Laboratory Practices.pptx
Good Laboratory Practices.pptxGood Laboratory Practices.pptx
Good Laboratory Practices.pptx
VUJJINIKHILKUMAR
 

Semelhante a Glp (20)

GLP.ppt
GLP.pptGLP.ppt
GLP.ppt
 
GLP.ppt
GLP.pptGLP.ppt
GLP.ppt
 
Glp
GlpGlp
Glp
 
Glp
GlpGlp
Glp
 
Good Laboratory Practice (GLP)
Good Laboratory Practice (GLP)Good Laboratory Practice (GLP)
Good Laboratory Practice (GLP)
 
GLP
GLPGLP
GLP
 
Good Laboratory Practices
Good Laboratory PracticesGood Laboratory Practices
Good Laboratory Practices
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Good Laboratory Practices.pptx
Good Laboratory Practices.pptxGood Laboratory Practices.pptx
Good Laboratory Practices.pptx
 
GLP_1.pdf
GLP_1.pdfGLP_1.pdf
GLP_1.pdf
 
Glp.
Glp.Glp.
Glp.
 
GLP Good Laboratory Practices Presentati
GLP Good Laboratory Practices PresentatiGLP Good Laboratory Practices Presentati
GLP Good Laboratory Practices Presentati
 
good-ward.ppt
good-ward.pptgood-ward.ppt
good-ward.ppt
 
Cro perspectives
Cro perspectivesCro perspectives
Cro perspectives
 
GLP DRA.pptx
GLP DRA.pptxGLP DRA.pptx
GLP DRA.pptx
 
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxGOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
 
Audit monitoring and inspections cro perspectives
Audit monitoring and inspections cro perspectivesAudit monitoring and inspections cro perspectives
Audit monitoring and inspections cro perspectives
 
Training Program
Training ProgramTraining Program
Training Program
 
WJPR 6039
WJPR 6039 WJPR 6039
WJPR 6039
 
Good lab practices (GLP)
Good lab practices (GLP)Good lab practices (GLP)
Good lab practices (GLP)
 

Mais de National Institute of Biologics

Canonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulinsCanonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulins
National Institute of Biologics
 

Mais de National Institute of Biologics (20)

Waters protein therapeutics application proctocols
Waters protein therapeutics application proctocolsWaters protein therapeutics application proctocols
Waters protein therapeutics application proctocols
 
Potential aggregation prone regions in biotherapeutics
Potential aggregation prone regions in biotherapeuticsPotential aggregation prone regions in biotherapeutics
Potential aggregation prone regions in biotherapeutics
 
How the biologics landscape is evolving
How the biologics landscape is evolvingHow the biologics landscape is evolving
How the biologics landscape is evolving
 
Evaluation of antibody drugs quality safety
Evaluation of antibody drugs quality safetyEvaluation of antibody drugs quality safety
Evaluation of antibody drugs quality safety
 
Approved m abs_feb_2015
Approved m abs_feb_2015Approved m abs_feb_2015
Approved m abs_feb_2015
 
Translating next generation sequencing to practice
Translating next generation sequencing to practiceTranslating next generation sequencing to practice
Translating next generation sequencing to practice
 
From biomarkers to diagnostics –the road to success
From biomarkers to diagnostics –the road to successFrom biomarkers to diagnostics –the road to success
From biomarkers to diagnostics –the road to success
 
Defining your-target-product-profile in-vitro-diagnostic-products
Defining your-target-product-profile in-vitro-diagnostic-productsDefining your-target-product-profile in-vitro-diagnostic-products
Defining your-target-product-profile in-vitro-diagnostic-products
 
Accelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesAccelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapies
 
Canonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulinsCanonical structures for the hypervariable regions of immunoglobulins
Canonical structures for the hypervariable regions of immunoglobulins
 
Canonical correlation
Canonical correlationCanonical correlation
Canonical correlation
 
Development trends for human monoclonal antibody therapeutics
Development trends for human monoclonal antibody therapeuticsDevelopment trends for human monoclonal antibody therapeutics
Development trends for human monoclonal antibody therapeutics
 
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
 
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
 
Therapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammationTherapeutic antibodies for autoimmunity and inflammation
Therapeutic antibodies for autoimmunity and inflammation
 
Introduction to current and future protein therapeutics - a protein engineeri...
Introduction to current and future protein therapeutics - a protein engineeri...Introduction to current and future protein therapeutics - a protein engineeri...
Introduction to current and future protein therapeutics - a protein engineeri...
 
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
Pharmaceutical monoclonal antibodies   production - guidelines to cell engine...Pharmaceutical monoclonal antibodies   production - guidelines to cell engine...
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
 
Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...Intended use of reference products & who international standards or reference...
Intended use of reference products & who international standards or reference...
 
How dissimilarly similar are biosimilars
How dissimilarly similar are biosimilarsHow dissimilarly similar are biosimilars
How dissimilarly similar are biosimilars
 
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...
Evaluation of similar biotherapeutic products (SBP's)   scientific principles ...Evaluation of similar biotherapeutic products (SBP's)   scientific principles ...
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...
 

Último

Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Victor Rentea
 

Último (20)

ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptx
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 

Glp

  • 1. GLP
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. What happens if a workplace does not comply with federal Good Laboratory Practice standards?
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.